Asepha

Founded in 2025, Asepha is focused on providing innovative automation solutions for pharmacies. The company is headquartered in Toronto, Canada.Asepha specializes in AI-powered workflow automation solutions designed specifically for the pharmacy sector. Its core product offerings include automatic prescription filtering and data entry into Pharmacy Management Systems (PMS) and Electronic Health Records (EHR), which streamline manual tasks to enhance operational efficiency. Asepha's technology captures critical data to assess patient eligibility for medications, thereby reducing delays in therapy initiation. The company also provides a Call & SMS Assistant to alleviate the workload on pharmacy staff by addressing common inquiries and offering updates on prescription statuses. Furthermore, Asepha's medication reconciliation tools identify discrepancies in medication lists, and its medication review function highlights potential drug therapy problems for pharmacist review.Asepha generates revenue primarily through subscriptions to its suite of AI-driven pharmacy automation tools. Clients, including retail and institutional pharmacies, engage with Asepha’s platforms on a subscription basis, which may include tiered pricing models based on the number of users or the scale of operations. As part of their offerings, Asepha’s flagship products facilitate efficient workflows, leading to increased productivity and revenue growth for their pharmacy clients. The transaction structure typically involves direct business-to-business interactions, where pharmacies pay for access to specific services such as instant prior authorization and medication reconciliation. The company is planning to introduce new products designed to further enhance pharmacy automation capabilities and is targeting expansion into additional markets within North America and potentially into Europe by the end of 2026.

1. Seed

   Jul 9, 2025

   Amount

   $4M

   Investors

   Locked